Darejan Lomidze

537 total citations
17 papers, 336 citations indexed

About

Darejan Lomidze is a scholar working on Surgery, Pathology and Forensic Medicine and Genetics. According to data from OpenAlex, Darejan Lomidze has authored 17 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 9 papers in Pathology and Forensic Medicine and 6 papers in Genetics. Recurrent topics in Darejan Lomidze's work include Management of metastatic bone disease (10 papers), Spine and Intervertebral Disc Pathology (9 papers) and Glioma Diagnosis and Treatment (6 papers). Darejan Lomidze is often cited by papers focused on Management of metastatic bone disease (10 papers), Spine and Intervertebral Disc Pathology (9 papers) and Glioma Diagnosis and Treatment (6 papers). Darejan Lomidze collaborates with scholars based in Slovenia, United States and Germany. Darejan Lomidze's co-authors include Douglas Guedes de Castro, Sunita Ghosh, Lucyna Kępka, Wilson Roa, Juliana Matiello, Elena Fidarova, V. Sinaika, Narendra Kumar, D. Hentati and Eduardo Rosenblatt and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Darejan Lomidze

16 papers receiving 331 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Darejan Lomidze Slovenia 7 251 163 86 86 64 17 336
D. Hentati Tunisia 6 252 1.0× 166 1.0× 99 1.2× 88 1.0× 25 0.4× 16 357
Paola Anselmo Italy 9 80 0.3× 125 0.8× 54 0.6× 53 0.6× 55 0.9× 25 271
F. Thillays France 11 170 0.7× 281 1.7× 142 1.7× 49 0.6× 70 1.1× 42 422
G.K. Hunter United States 10 135 0.5× 253 1.6× 55 0.6× 60 0.7× 149 2.3× 25 429
C. Barney United States 8 130 0.5× 189 1.2× 36 0.4× 74 0.9× 70 1.1× 22 314
Hiral P. Fontanilla United States 9 94 0.4× 161 1.0× 38 0.4× 90 1.0× 46 0.7× 15 289
Matthew Susko United States 11 77 0.3× 110 0.7× 70 0.8× 34 0.4× 115 1.8× 23 255
Z.A. Siddiqui United States 11 60 0.2× 132 0.8× 47 0.5× 54 0.6× 83 1.3× 23 332
C Lévy-Piedbois France 9 222 0.9× 101 0.6× 108 1.3× 20 0.2× 63 1.0× 14 404
B. Diletto Italy 9 92 0.4× 98 0.6× 26 0.3× 29 0.3× 34 0.5× 22 208

Countries citing papers authored by Darejan Lomidze

Since Specialization
Citations

This map shows the geographic impact of Darejan Lomidze's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Darejan Lomidze with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Darejan Lomidze more than expected).

Fields of papers citing papers by Darejan Lomidze

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Darejan Lomidze. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Darejan Lomidze. The network helps show where Darejan Lomidze may publish in the future.

Co-authorship network of co-authors of Darejan Lomidze

This figure shows the co-authorship network connecting the top 25 collaborators of Darejan Lomidze. A scholar is included among the top collaborators of Darejan Lomidze based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Darejan Lomidze. Darejan Lomidze is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Rades, Dirk, Darejan Lomidze, Fernando López‐Campos, et al.. (2024). Radiotherapy with 15 × 2.633 Gy vs. 20 × 2.0 Gy in Patients with Malignant Spinal Cord Compression and Favorable Survival Prognoses: A Secondary Analysis of the RAMSES-01 Trial. Cancers. 16(20). 3436–3436. 1 indexed citations
2.
Rades, Dirk, Darejan Lomidze, Fernando López‐Campos, et al.. (2024). Radiotherapy for Metastatic Epidural Spinal Cord Compression with Increased Doses: Final Results of the RAMSES-01 Trial. Cancers. 16(6). 1149–1149. 3 indexed citations
3.
Rades, Dirk, Jon Cacicedo, Darejan Lomidze, et al.. (2022). A New and Easy-to-Use Survival Score for Patients Irradiated for Metastatic Epidural Spinal Cord Compression. Practical Radiation Oncology. 12(4). 354–362. 6 indexed citations
4.
Rades, Dirk, Florian Cremers, Jon Cacicedo, et al.. (2022). A New Clinical Instrument for Estimating the Ambulatory Status after Irradiation for Malignant Spinal Cord Compression. Cancers. 14(15). 3827–3827. 5 indexed citations
5.
Rades, Dirk, Barbara Šegedin, Steven E. Schild, et al.. (2022). Identifying patients with malignant spinal cord compression (MSCC) near end of life who can benefit from palliative radiotherapy. Radiation Oncology. 17(1). 143–143. 3 indexed citations
6.
Rades, Dirk, Jon Cacicedo, Darejan Lomidze, et al.. (2022). Prognostic Value of Preclinical Markers after Radiotherapy of Metastatic Spinal Cord Compression—An Additional Analysis of Patients from Two Prospective Trials. Cancers. 14(10). 2547–2547. 3 indexed citations
7.
Rades, Dirk, Jon Cacicedo, Antonio J. Conde-Moreno, et al.. (2021). Comparison of 5 × 5 Gy and 10 × 3 Gy for metastatic spinal cord compression using data from three prospective trials. Radiation Oncology. 16(1). 7–7. 9 indexed citations
8.
Rades, Dirk, Jon Cacicedo, Antonio J. Conde-Moreno, et al.. (2019). Precision Radiation Therapy for Metastatic Spinal Cord Compression: Final Results of the PRE-MODE Trial. International Journal of Radiation Oncology*Biology*Physics. 106(4). 780–789. 19 indexed citations
9.
Ghosh, Sunita, Sarah Baker, Douglas Guedes de Castro, et al.. (2018). Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma. Radiotherapy and Oncology. 127(1). 114–120. 7 indexed citations
10.
Rades, Dirk, Jon Cacicedo, Antonio J. Conde-Moreno, et al.. (2017). High-precision radiotherapy of motor deficits due to metastatic spinal cord compression (PRE-MODE): a multicenter phase 2 study. BMC Cancer. 17(1). 818–818. 4 indexed citations
11.
Castro, Douglas Guedes de, Juliana Matiello, Wilson Roa, et al.. (2017). Survival Outcomes With Short-Course Radiation Therapy in Elderly Patients With Glioblastoma: Data From a Randomized Phase 3 Trial. International Journal of Radiation Oncology*Biology*Physics. 98(4). 931–938. 31 indexed citations
12.
Lomidze, Darejan, et al.. (2016). Biodosimetry of Persons Chronically Exposed to Low and Therapeutic Doses of Ionizing Radiation. PubMed. 7. 12–12. 5 indexed citations
13.
Fidarova, Elena, Lucyna Kępka, V. Sinaika, et al.. (2016). 9: Quality of Life in Elderly/Frail Patients with Glioblastoma Multiforme: Results of a Randomized Phase III Study Comparing Short and Standard Course of Radiotherapy. Radiotherapy and Oncology. 120. S4–S4. 2 indexed citations
14.
Roa, Wilson, Lucyna Kępka, Narendra Kumar, et al.. (2015). International Atomic Energy Agency Randomized Phase III Study of Radiation Therapy in Elderly and/or Frail Patients With Newly Diagnosed Glioblastoma Multiforme. Journal of Clinical Oncology. 33(35). 4145–4150. 213 indexed citations
15.
Socha, Joanna, Lucyna Kępka, Sunita Ghosh, et al.. (2015). Outcome of treatment of recurrent glioblastoma multiforme in elderly and/or frail patients. Journal of Neuro-Oncology. 126(3). 493–498. 24 indexed citations
16.
Fidarova, Elena, С. И. Ткачев, V. Sinaika, et al.. (2015). OC-0193: Current radiotherapy capacity in post-Soviet countries; an IAEA survey. Radiotherapy and Oncology. 115. S97–S98.
17.
Kępka, Lucyna, Wilson Roa, V. Sinaika, et al.. (2014). PD-0519: Short course vs. standard course radiotherapy, in elderly and/or fragile patients with glioblastoma multiforme. Radiotherapy and Oncology. 111. S204–S205. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026